FDANonrulemakingFDA-2021-N-0951

Who commented on this docket

Reconsidering Mandatory Opioid Prescriber Education Through a Risk Evaluation and Mitigation Strategy (REMS) in an Evolving Opioid Crisis; Public Workshop; Request for Comments

9 organizations filed 9 public comments on Reconsidering Mandatory Opioid Prescriber Education Through a Risk Evaluation and Mitigation Strategy (REMS) in an Evolving Opioid Crisis; Public Workshop; Request for Comments, at the Food and Drug Administration. The comment window closed 1698d ago.

Organizations
9
Comments
9
RIN
Comment window
closed 1698d ago

Abstract

OPEN

Commenters (9)

View this docket on regulations.gov →

Attribution is name-based and imperfect. regulations.gov data is public record.